609 related articles for article (PubMed ID: 34757869)
1. The Role of Inhaled Corticosteroids (ICS) in Critically Ill Patients With COVID-19: A Multicenter, Cohort Study.
Al Sulaiman K; Aljuhani O; Al Aamer K; Al Shaya O; Al Shaya A; Alsaeedi AS; Alhubaishi A; Altebainawi AF; Al Harthi A; Albelwi S; Almutairi R; Alsubaie N; Alsallum A; Korayem GB; Alfahed A; Kensara R; Altebainawi EF; Alenezi RS; Alsulaiman T; Al Enazi H; Vishwakarma R; Al Dabbagh T; Bakhsh U; Al Ghamdi G
J Intensive Care Med; 2022 Feb; 37(2):248-257. PubMed ID: 34757869
[No Abstract] [Full Text] [Related]
2. Evaluation of inhaled nitric oxide (iNO) treatment for moderate-to-severe ARDS in critically ill patients with COVID-19: a multicenter cohort study.
Al Sulaiman K; Korayem GB; Altebainawi AF; Al Harbi S; Alissa A; Alharthi A; Kensara R; Alfahed A; Vishwakarma R; Al Haji H; Almohaimid N; Al Zumai O; Alrubayan F; Asiri A; Alkahtani N; Alolayan A; Alsohimi S; Melibari N; Almagthali A; Aljahdali S; Alenazi AA; Alsaeedi AS; Al Ghamdi G; Al Faris O; Alqahtani J; Al Qahtani J; Alshammari KA; Alshammari KI; Aljuhani O
Crit Care; 2022 Oct; 26(1):304. PubMed ID: 36192801
[TBL] [Abstract][Full Text] [Related]
3. The impact of HMG-CoA reductase inhibitors use on the clinical outcomes in critically ill patients with COVID-19: A multicenter, cohort study.
Al Sulaiman K; Aljuhani O; Korayem GB; Altebainawi AF; Al Harbi S; Al Shaya A; Badreldin HA; Kensara R; Alharthi AF; Alghamdi J; Alawad A; Alotaibi R; Kharbosh A; Al Muqati H; Alhuwahmel A; Almusallam M; Albarrak G; Al Sulaihim I; Alanazi B; Al-Dosari BS; Vishwakarma R; Alsaeedi AS; Al Ghamdi G; Alkofide H; Al-Dorzi HM
Front Public Health; 2022; 10():877944. PubMed ID: 36033795
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of Early Tocilizumab Effect on Multiorgan Dysfunction in Critically Ill Patients With COVID-19: A Propensity Score-Matched Study.
Aljuhani O; Korayem GB; Altebainawi AF; Al Harthi A; Badreldin HA; Alsalloum MA; Eljaaly K; Alharbi A; Aljehani R; Vishwakarma R; Alenazi AA; Alalawi M; Alissa A; Al Aamer K; Al Enazi H; Almusallam M; Alshehri A; Bukhari R; Alasmari G; AlQahtani MM; Al Shammari S; Alsulaymi HO; Al Sulaiman K
J Intensive Care Med; 2023 Jun; 38(6):534-543. PubMed ID: 36683420
[No Abstract] [Full Text] [Related]
5. Evaluation of Low-Dose Aspirin use among Critically Ill Patients with COVID-19: A Multicenter Propensity Score Matched Study.
Al Harthi AF; Aljuhani O; Korayem GB; Altebainawi AF; Alenezi RS; Al Harbi S; Gramish J; Kensara R; Hafidh A; Al Enazi H; Alawad A; Alotaibi R; Alshehri A; Alhuthaili O; Vishwakarma R; Bin Saleh K; Alsulaiman T; Alqahtani RA; Hussain S; Almazrou S; Al Sulaiman K
J Intensive Care Med; 2022 Sep; 37(9):1238-1249. PubMed ID: 35450493
[TBL] [Abstract][Full Text] [Related]
6. Patient characteristics, clinical course and factors associated to ICU mortality in critically ill patients infected with SARS-CoV-2 in Spain: A prospective, cohort, multicentre study.
Ferrando C; Mellado-Artigas R; Gea A; Arruti E; Aldecoa C; Bordell A; Adalia R; Zattera L; Ramasco F; Monedero P; Maseda E; Martínez A; Tamayo G; Mercadal J; Muñoz G; Jacas A; Ángeles G; Castro P; Hernández-Tejero M; Fernandez J; Gómez-Rojo M; Candela Á; Ripollés J; Nieto A; Bassas E; Deiros C; Margarit A; Redondo FJ; Martín A; García N; Casas P; Morcillo C; Hernández-Sanz ML;
Rev Esp Anestesiol Reanim (Engl Ed); 2020 Oct; 67(8):425-437. PubMed ID: 32800622
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the use of methylprednisolone and dexamethasone in asthma critically ill patients with COVID-19: a multicenter cohort study.
Al Sulaiman K; Aljuhani O; Korayem GB; Altebainawi A; Alharbi R; Assadoon M; Vishwakarma R; Ismail NH; Alshehri AA; Al Mutairi FE; AlFaifi M; Alharthi AF; Alenazi AA; Alalawi M; Al Zumai O; Al Haji H; Al Dughaish ST; Alawaji AS; Alhaidal HA; Al Ghamdi G
BMC Pulm Med; 2023 Aug; 23(1):315. PubMed ID: 37641042
[TBL] [Abstract][Full Text] [Related]
8. When antivirals backfire: An evaluation of favipiravir's clinical outcomes in critically ill patients with COVID-19: A multicenter cohort study.
Al Sulaiman K; Aljuhani O; Korayem GB; Altebainawi AF; AlFaifi M; Nahari M; Almagthali A; Thabit AK; Alhajaji R; Alharbi R; Kahtani K; Alenazi AA; Alharbi A; Alghwainm MM; Alotaibi SM; Alghamdi YS; Alotaibi S; Alonazi SH; Almutairi JM; Vishwakarma R
J Infect Public Health; 2023 Sep; 16(9):1492-1499. PubMed ID: 37355406
[TBL] [Abstract][Full Text] [Related]
9. Clinical features and outcomes of critically ill patients with coronavirus disease 2019 (COVID-19): A multicenter cohort study.
Al Sulaiman KA; Aljuhani O; Eljaaly K; Alharbi AA; Al Shabasy AM; Alsaeedi AS; Al Mutairi M; Badreldin HA; Al Harbi SA; Al Haji HA; Al Zumai OI; Vishwakarma RK; Alkatheri A
Int J Infect Dis; 2021 Apr; 105():180-187. PubMed ID: 33601030
[TBL] [Abstract][Full Text] [Related]
10. Dexamethasone versus methylprednisolone for multiple organ dysfunction in COVID-19 critically ill patients: a multicenter propensity score matching study.
Aljuhani O; Korayem GB; Altebainawi AF; AlMohammady D; Alfahed A; Altebainawi EF; Aldhaeefi M; Badreldin HA; Vishwakarma R; Almutairi FE; Alenazi AA; Alsulaiman T; Alqahtani RA; Al Dhahri F; Aldardeer N; Alenazi AO; Al Harbi S; Kensara R; Alalawi M; Al Sulaiman K
BMC Infect Dis; 2024 Feb; 24(1):189. PubMed ID: 38350878
[TBL] [Abstract][Full Text] [Related]
11. The Association of New-Onset Acute Kidney Injury and Mortality in Critically Ill Patients With COVID-19 With Less Severe Clinical Conditions at Admission: A Moderation Analysis.
Regolisti G; Maggiore U; Di Mario F; Gentile M; Benigno GD; Gandolfini I; Pistolesi V; Morabito S; Barbagallo M; Picetti E; Fiaccadori E
Front Med (Lausanne); 2022; 9():799298. PubMed ID: 35372447
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of thiamine as adjunctive therapy in COVID-19 critically ill patients: a two-center propensity score matched study.
Al Sulaiman K; Aljuhani O; Al Dossari M; Alshahrani A; Alharbi A; Algarni R; Al Jeraisy M; Al Harbi S; Al Katheri A; Al Eidan F; Al Bekairy AM; Al Qahtani N; Al Muqrin M; Vishwakarma R; Al Ghamdi G
Crit Care; 2021 Jun; 25(1):223. PubMed ID: 34193235
[TBL] [Abstract][Full Text] [Related]
13. Early corticosteroids are associated with lower mortality in critically ill patients with COVID-19: a cohort study.
Monedero P; Gea A; Castro P; Candela-Toha AM; Hernández-Sanz ML; Arruti E; Villar J; Ferrando C;
Crit Care; 2021 Jan; 25(1):2. PubMed ID: 33397463
[TBL] [Abstract][Full Text] [Related]
14. Clinical characteristics and outcome of critically ill COVID-19 patients with acute kidney injury: a single centre cohort study.
Lowe R; Ferrari M; Nasim-Mohi M; Jackson A; Beecham R; Veighey K; Cusack R; Richardson D; Grocott M; Levett D; Dushianthan A;
BMC Nephrol; 2021 Mar; 22(1):92. PubMed ID: 33722189
[TBL] [Abstract][Full Text] [Related]
15. Association between continuous renal replacement therapy and 28-day mortality of critically ill patients with COVID-19 receiving mechanical ventilation.
Xu X; Liu K; Cheng P; Huang Y; Huang C; Wu W; Xing C; Mao H; Liu Y
Clin Nephrol; 2021 Oct; 96(4):207-215. PubMed ID: 34236306
[TBL] [Abstract][Full Text] [Related]
16. The safety and effectiveness of tocilizumab in older adult critically ill patients with COVID-19: a multicenter, cohort study.
Korayem GB; Aljuhani O; Altebainawi AF; Shaya AIA; Alnajjar LI; Alissa A; Aldhaeefi M; Kensara R; Al Muqati H; Alhuwahmel A; Alhuthaili O; Vishwakarma R; Aldardeer N; Eljaaly K; Alharbi A; Harbi SA; Katheri AA; Bekairy AMA; Aljedai A; Al Sulaiman K
Int J Infect Dis; 2022 Sep; 122():252-259. PubMed ID: 35605948
[TBL] [Abstract][Full Text] [Related]
17. Clinical course and predictors of 60-day mortality in 239 critically ill patients with COVID-19: a multicenter retrospective study from Wuhan, China.
Xu J; Yang X; Yang L; Zou X; Wang Y; Wu Y; Zhou T; Yuan Y; Qi H; Fu S; Liu H; Xia J; Xu Z; Yu Y; Li R; Ouyang Y; Wang R; Ren L; Hu Y; Xu D; Zhao X; Yuan S; Zhang D; Shang Y
Crit Care; 2020 Jul; 24(1):394. PubMed ID: 32631393
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of zinc sulfate as an adjunctive therapy in COVID-19 critically ill patients: a two center propensity-score matched study.
Al Sulaiman K; Aljuhani O; Al Shaya AI; Kharbosh A; Kensara R; Al Guwairy A; Alharbi A; Algarni R; Al Harbi S; Vishwakarma R; Korayem GB
Crit Care; 2021 Oct; 25(1):363. PubMed ID: 34663411
[TBL] [Abstract][Full Text] [Related]
19. Structured ICU resource management in a pandemic is associated with favorable outcome in critically ill COVID‑19 patients.
Klein SJ; Bellmann R; Dejaco H; Eschertzhuber S; Fries D; Furtwängler W; Gasteiger L; Hasibeder W; Helbok R; Hochhold C; Hofer S; Kirchmair L; Krismer C; Ladner E; Lehner GF; Mathis S; Mayr A; Mittermayr M; Peer A; Preuß Hernández C; Reitter B; Ströhle M; Swoboda M; Thomé C; Joannidis M
Wien Klin Wochenschr; 2020 Nov; 132(21-22):653-663. PubMed ID: 33170333
[TBL] [Abstract][Full Text] [Related]
20. The Impact of Recombinant Human Erythropoietin Administration in Critically ill COVID-19 Patients: A Multicenter Cohort Study.
Al Sulaiman K; Aljuhani O; Korayem GB; Altebainawi AF; Vishwakarma R; AlFaifi M; Alsohimi S; Alrayes A; Albishi S; Alqahtani R; Alalawi M; Al Sulaihim I; Alanazi TA; Alqahtani RA; Almagthali A; Jomah S; Alshlowi A; Alshammari TR; Alzahrani SS; Abdulqader MI
Clin Appl Thromb Hemost; 2023; 29():10760296231218216. PubMed ID: 38073058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
